AKAO - Achaogen, Inc.
(NaN%)
We couldn't determine Recommendation based on the data we have.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Achaogen, Inc. (AKAO) - http://www.achaogen.com
Discovers, develops and commercializes novel anti-bacterial to treat multi-drug resistant gram negative infectionsExchange - US OTC
Industry - Pharmaceuticals: Other
Sector - Health Technology
CEO - Blake Wise
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2025 and future.
Know the Stock © 2025 and future.